ClariVest Asset Management’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $533K | Hold |
22,964
| – | – | 0.05% | 345 |
|
|
2024
Q2 | $533K | Sell |
22,964
-24,784
| -52% | -$575K | 0.05% | 345 |
|
|
2024
Q1 | $980K | Buy |
47,748
+7,568
| +19% | +$155K | 0.1% | 272 |
|
|
2023
Q4 | $862K | Sell |
40,180
-2,721
| -6% | -$58.4K | 0.05% | 286 |
|
|
2023
Q3 | $885K | Buy |
42,901
+38
| +0.1% | +$784 | 0.05% | 256 |
|
|
2023
Q2 | $1.27M | Sell |
42,863
-6,404
| -13% | -$189K | 0.06% | 198 |
|
|
2023
Q1 | $1.14M | Buy |
49,267
+39
| +0.1% | +$899 | 0.05% | 268 |
|
|
2022
Q4 | $1.37M | Sell |
49,228
-152
| -0.3% | -$4.22K | 0.07% | 230 |
|
|
2022
Q3 | $1.51M | Sell |
49,380
-5,258
| -10% | -$161K | 0.07% | 196 |
|
|
2022
Q2 | $1.61M | Sell |
54,638
-11,000
| -17% | -$324K | 0.07% | 216 |
|
|
2022
Q1 | $2.11M | Hold |
65,638
| – | – | 0.08% | 208 |
|
|
2021
Q4 | $2.93M | Sell |
65,638
-5,828
| -8% | -$260K | 0.09% | 200 |
|
|
2021
Q3 | $3.61M | Sell |
71,466
-3,779
| -5% | -$191K | 0.12% | 178 |
|
|
2021
Q2 | $5.9M | Buy |
75,245
+58,039
| +337% | +$4.55M | 0.2% | 103 |
|
|
2021
Q1 | $982K | Buy |
17,206
+473
| +3% | +$27K | 0.03% | 289 |
|
|
2020
Q4 | $1.4M | Sell |
16,733
-22,764
| -58% | -$1.91M | 0.05% | 237 |
|
|
2020
Q3 | $1.41M | Buy |
39,497
+8,158
| +26% | +$292K | 0.05% | 268 |
|
|
2020
Q2 | $757K | Buy |
+31,339
| New | +$757K | 0.02% | 351 |
|